Search Results

You are looking at 231 - 240 of 1,592 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes

Ryan D. Nipp, Leah L. Thompson, Brandon Temel, Charn-Xin Fuh, Christine Server, Paul S. Kay, Sophia Landay, Daniel E. Lage, Lara Traeger, Erin Scott, Vicki A. Jackson, Nora K. Horick, Joseph A. Greer, Areej El-Jawahri, and Jennifer S. Temel

believed prohibited informed consent or study participation. Study Measures Sociodemographic and Clinical Characteristics Participants completed a demographic questionnaire to report their race, relationship status, work status, education level, annual

Full access

Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer

Michael Xiang and Elizabeth A. Kidd

-Medicare linkage, patient follow-up was through December 2014. Statistical Analysis Baseline characteristics were compared using the chi-square or Wilcoxon rank-sum test. Multivariable logistic regression was used to identify predictors for receiving cisplatin

Full access

A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis

Reith R. Sarkar, Katherine E. Fero, Daniel M. Seible, Neil Panjwani, Rayna K. Matsuno, and James D. Murphy

. Analyses were conducted using SAS 9.4 (SAS Institute Inc). Results Cohort Characteristics Of the 21,500 patients in the study cohort, 11,298 (52.5%) presented with metastatic disease, 3,092 (14.4%) were in the resectable group, and 7,110 (33.1%) were in the

Full access

Pilot Randomized Controlled Trial of an Educational Video for CAR T-Cell Therapy Recipients

P. Connor Johnson, Tejaswini Dhawale, Richard A. Newcomb, Ana Barata, Kyle Karpinski, Mitchell W. Lavoie, Dagny Vaughn, Kathleen Hennessey, David Schneider, Hermioni L. Amonoo, Angelo Volandes, and Areej El-Jawahri

compared baseline characteristics between both study arms using Fisher’s exact test for categorical variables and t tests for continuous variables. We calculated feasibility by determining the percentage of eligible patients enrolling in the study. We

Full access

Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer

Merel J.M. van Velzen, Marieke Pape, Mirjam A.G. Sprangers, Jessy Joy van Kleef, Bianca Mostert, Laurens V. Beerepoot, Marije Slingerland, Elske C. Gootjes, Ronald Hoekstra, Lonneke V. van de Poll-Franse, Nadia Haj Mohammad, and Hanneke W.M. van Laarhoven

were also enrolled in the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP). 16 Data regarding patient characteristics, diagnosis, and (initial) treatment were routinely extracted from patients’ electronic health

Full access

Agreement in Metastatic Spinal Cord Compression

Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Úrsula Pérez-Ramírez, Javier Zamora, and the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis

in 182 spinal segments. Table 1 shows sample characteristics. Table 1 Sample Characteristics There were more than 5 readers for each specialty and degree of professional experience. However, only 3 readers worked at category 2

Full access

Association Between Chronologic Age and Geriatric Assessment–Identified Impairments: Findings From the CARE Registry

Smith Giri, Mustafa Al-Obaidi, Alice Weaver, Kelly M. Kenzik, Andrew McDonald, Deanna Clark, Crystal Young-Smith, Ravi Paluri, Lakshmin Nandagopal, Olumide Gbolahan, Mackenzi Pergolotti, Smita Bhatia, and Grant R. Williams

for GA impairment and construction of the CARE Frailty Index are provided in supplemental eAppendices 1 and 2 . Statistical Analysis We compared baseline characteristics between the 3 age groups (60–64, 65–74, and ≥75 years) using appropriate

Full access

Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis

Victoria S. Blinder, Elizabeth Garrett-Mayer, Paul B. Jacobsen, Mary May Kozlik, Merry Jennifer Markham, Robert D. Siegel, Arif H. Kamal, Stephanie T.S. Crist, Jon Rosenthal, Anne C. Chiang, and on behalf of the ASCO Quality Publications Task Force*

. All analyses were performed in R/RStudio (R Project for Statistical Computing) and the lme4 library was used for estimation of the mixed-effects logistic regression model. Results Practice Characteristics A total of 192 practices

Full access

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Rebecca M. Shulman, David S. Weinberg, Eric A. Ross, Karen Ruth, Glenn F. Rall, Anthony J. Olszanski, James Helstrom, Michael J. Hall, Julia Judd, David Y.T. Chen, Robert G. Uzzo, Timothy P. Dougherty, Riley Williams, Daniel M. Geynisman, Carolyn Y. Fang, Richard I. Fisher, Marshall Strother, Erica Huelsmann, Sunil Adige, Peter D. Whooley, Kevin Zarrabi, Brinda Gupta, Pritish Iyer, Melissa McShane, Hilario Yankey, Charles T. Lee, Nina Burbure, Lauren E. Laderman, Julie Giurintano, Samuel Reiss, and Eric M. Horwitz

extended to 90 days before the first vaccine dose. Early symptom onset was defined as an adverse event within 24 hours of vaccination. Baseline characteristics of the study population were tabulated separately for patients without cancer, unselected

Full access

Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?

Shubham Sharma, Christopher M. Booth, Elizabeth A. Eisenhauer, and Bishal Gyawali

published in the top journals, 243 were related to oncology. The final study cohort included 90 editorials based on the inclusion and exclusion criteria ( Figure 1 ). Characteristics of the editorials and their accompanying clinical trials are shown in